skip to Main Content

CAMH researcher’s leading-edge therapy targets brain chemistry of addiction

CAMH and MaRS Innovation partner on innovative approach to nicotine addiction

Centre for Addiction and Mental Health (CAMH) LogoTORONTO (Dec. 17, 2009) — Grappling with nicotine addiction is never easy, but a new drug therapy – developed by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) – brings promise to one of our great public health challenges.

The experimental medication in development at Dr. Liu’s lab targets the brain chemistry associated with addiction by disrupting a specific receptor-receptor interaction.

Proof-of-concept data demonstrate that this therapy decreases addictive behavior associated with nicotine and alcohol in preclinical models.

Continue Reading
Back To Top